Real-Time Multi-Step View Reconstruction for a Virtual Teleconference System

Autor: B. J. Lei, E. A. Hendriks

Publikováno v: EURASIP Journal on Advances in Signal Processing, Vol 2002, Iss 10, Pp 1067-1087 (2002)

We propose a real-time multi-step view reconstruction algorithm and we tune its implementation to a virtual teleconference application. Theoretical motivations and practical implementation issues of the algorithm are detailed. The proposed algorithm

Externí odkaz: https://doaj.org/article/ff8050ead01b4cb792ae047fa5211909

Generation of synthetic ground glass nodules using generative adversarial networks (GANs)

Autor: Zhixiang Wang, Zhen Zhang, Ying Feng, Lizza E. L. Hendriks, Razvan L. Miclea, Hester Gietema, Janna Schoenmaekers, Andre Dekker, Leonard Wee, Alberto Traverso

Publikováno v: European Radiology Experimental, Vol 6, Iss 1, Pp 1-12 (2022)

Abstract Background Data shortage is a common challenge in developing computer-aided diagnosis systems. We developed a generative adversarial network (GAN) model to generate synthetic lung lesions mimicking ground glass nodules (GGNs). Methods We use

Externí odkaz: https://doaj.org/article/e0cf50d997d54f8c81e2bb374ed74cf4

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

Autor: Marinda Meertens, M. Benthe Muntinghe-Wagenaar, Barend J. Sikkema, Marta Lopez-Yurda, Valesca P. Retèl, Marthe S. Paats, Rob Ter Heine, Ed Schuuring, Wim Timens, Daan J. Touw, Job F. M. van Boven, Adrianus. J. de Langen, Sayed M. S. Hashemi, Lizza E. L. Hendriks, Sander Croes, Michel M. van den Heuvel, Anne-Marie C. Dingemans, Ron H. J. Mathijssen, Egbert F. Smit, Alwin D. R. Huitema, Neeltje Steeghs, Anthonie J. van der Wekken

Publikováno v: Frontiers in Oncology, Vol 13 (2023)

BackgroundAlectinib is first-line therapy in patients with stage IV non-small cell lung carcinoma (NSCLC) and an anaplastic lymphoma kinase (ALK) fusion. A shorter median progression-free survival (mPFS) was observed when alectinib minimum plasma con

Externí odkaz: https://doaj.org/article/4457ff0cdd7b4bd9aa0922759784c7a7

Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics

Autor: Simon A. Keek, Manon Beuque, Sergey Primakov, Henry C. Woodruff, Avishek Chatterjee, Janita E. van Timmeren, Martin Vallières, Lizza E. L. Hendriks, Johannes Kraft, Nicolaus Andratschke, Steve E. Braunstein, Olivier Morin, Philippe Lambin

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

IntroductionThere is a cumulative risk of 20–40% of developing brain metastases (BM) in solid cancers. Stereotactic radiotherapy (SRT) enables the application of high focal doses of radiation to a volume and is often used for BM treatment. However,

Externí odkaz: https://doaj.org/article/a29dd364d66744579caa9035f29aaa08

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial

Autor: Nikki de Rouw, René J. Boosman, Jacobus A. Burgers, Alwin D. R. Huitema, Anne-Marie C. Dingemans, Hieronymus. J. Derijks, David M. Burger, Berber Piet, Lizza E. L. Hendriks, Bonne Biesma, Melinda A. Pruis, Daphne W. Dumoulin, Sander Croes, Ron H. J. Mathijssen, Michel M. van den Heuvel, Rob ter Heine

Publikováno v: Cancer Chemotherapy and Pharmacology, 91, 33-42
Cancer Chemotherapy and Pharmacology, 91(1), 33-42. Springer Verlag
Cancer Chemotherapy and Pharmacology, 91(1), 33-42. Springer-Verlag
Cancer Chemotherapy and Pharmacology, 91, 1, pp. 33-42

Item does not contain fulltext PURPOSE: Pemetrexed is a chemotherapeutic drug in the treatment of non-small cell lung cancer and mesothelioma. Optimized dosing of pemetrexed based on renal function instead of body surface area (BSA) is hypothesized t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f89d8fdab2aea47b4e702192ee6d7831
https://hdl.handle.net/2066/290955